Hormone-free on-demand contraceptive gel
Raised to date
$1.7M
of $2.4M offered across 2 Form D filings
Evofem Biosciences, Inc. is a biopharmaceutical company focused on women's sexual and reproductive health. They develop and commercialize hormone-free, patient-controlled solutions, providing women with greater control over their health choices. The company addresses unmet needs in contraception, vaginal infections, and sexually transmitted infections.
Hormone-free, patient-controlled solutions
$1.5M equity round, first sold Apr 2025: $750K sold, $750K still open
$1.5M round, first sold Apr 2025: $750K sold, $750K still open
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Jul 2, 2025 | Equity | $925K/ $925K | Form D |
| Apr 15, 2025 | Equity | $750K/ $1.5M | Form D |
Contraceptive vaginal gel
Phexxi is the first and only FDA-approved, hormone-free, on-demand contraceptive vaginal gel. Using a proprietary vaginal pH modulator, it is applied 0-60 minutes before intercourse to maintain a slightly acidic vaginal environment, which helps prevent sperm from fertilizing an egg.
Built for
Women seeking non-hormonal contraception and sexual health options
